文献速递妇产影像腹部技术与安全CT

卵巢癌患者的影像蛋白质组学

Radioproteomics in patients with ovarian cancer.
PubMed 文献 · Br J Radiol · 2021-06-11

本文综述影像蛋白质组学这一新兴领域,即将蛋白质组学与影像组学相结合,并探讨其在高浆液性卵巢癌中的应用。文中讨论了PROVAR和CPTA等卵巢癌蛋白质组学重要研究,以及烟酰胺N-甲基转移酶在肿瘤间质代谢调控中的核心作用,并介绍了一种将CT定性和影像组学特征与蛋白质组学分析整合的假设生成方法及该领域的未来方向。

要点

  • 影像蛋白质组学整合蛋白质组学与影像组学,用于高浆液性卵巢癌研究。
  • 烟酰胺N-甲基转移酶在肿瘤间质代谢调控中可能起核心作用。
  • 联合影像组学、蛋白质组学和基因组学分析可能推动精准医学发展。

核心结论

  • 影像组学、蛋白质组学和基因组学分析的联合进展有可能开启真正精准医学的时代,使治疗以肿瘤分子特征为中心而非基于经验知识,从而改变这一女性生殖系统癌症中死亡率最高的疾病的病程。

研究设计与样本

  • 本文为综述,讨论影像蛋白质组学在高浆液性卵巢癌中的应用,涵盖PROVAR和CPTA等蛋白质组学研究及近期研究,并考虑一种将CT定性和影像组学特征与蛋白质组学分析整合的假设生成方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radioproteomics is the integration of proteomics, the systematic study of the protein expression of an organism, with radiomics, the extraction and analysis of large numbers of quantitative features from medical images. This article examines this developing field, and it's application in high grade serous ovarian carcinoma. Seminal proteomic studies in the area of ovarian cancer, such as the PROVAR and CPTA studies are discussed, along side recent research, such as that highlighting the central role of methyltransferase nicotinamide N-methyltransferase as the metabolic regulation of cancer progression in the tumour stroma. Finally, this article considers a novel, hypothesis generating approach to integrate CT-based qualitative and radiomic features with proteomic analysis, and the future direction of the field. Combined advances in radiomic, proteomic and genomic analysis has the potential to signal the age of true precision medicine, where treatment is centered specifically on the molecular profile of the tumour, rather than based on empirical knowledge, thus altering the course of a disease that has the highest mortality of all cancers of the female reproductive system.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. McCague C, Beer L. Radioproteomics in patients with ovarian cancer. Br J Radiol. 2021. PMID: 34111953. doi:10.1259/bjr.20201331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。